Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 130.00 | |
5 mg | In stock | $ 320.00 | |
10 mg | In stock | $ 480.00 | |
25 mg | In stock | $ 786.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,480.00 | |
500 mg | In stock | $ 2,960.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 346.00 |
Description | Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity. |
Targets&IC50 | p38α:0.7 µM, p38α:1914 nM(Kd) |
Molecular Weight | 371.36 |
Formula | C19H18FN3O4 |
CAS No. | 249937-52-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.71 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ro-3201195 249937-52-8 MAPK p38 MAPK inhibitor inhibit